News

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...
Health service to make medications Mounjaro and Wegovy available after short consultation as part of war on obesity ...
Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...
An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...
An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...
GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...